Triplet ‐drug chemotherapy combined with anti‐EGFR antibody as an effective therapy for patients with initially unresectable metastatic colorectal cancer: a meta-analysis
The meta-analysis aimed to assess the clinical efficacy of chemotherapeutic triplet ‐drug regimen combined with anti‐EGFR antibody in patients with initially unresectable metastatic colorectal cancer (mCRC). A ...
Source: World Journal of Surgical Oncology - Category: Cancer & Oncology Authors: Muyou Tian, Huifen Li, Wenjing Dong, Yuhong Li, Ting Jiang, Yanhua Lv, Jianxiong Zeng, Xiaomei Jiang, Zhaofeng Yin and Jianjun Xiao Tags: Research Source Type: research